# Youseen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/youseen

- Industry: Pharmaceuticals
- Headquarters: Suzhou, China
- Website: www.youseen.com/
- Latest round: Series E (Aug 24, 2025)
- Investors on record: 10

## About

Founded in 2007 and based in Suzhou, China, SuZhou Youseen New Drug R&D Co., Ltd., trading as Youseen, has focused on the research and development of innovative traditional Chinese herbal medicines. The company has engaged in multiple development projects and in August 2025, it closed a round of venture funding from Foshan Venture Capital and Gortune Investment.

The company develops Chinese herbal drug products, with a portfolio of more than 40 projects under research and development, including treatments for chronic and metabolic disease-related conditions. Its products are intended for use by healthcare providers and pharmaceutical distributors and it also collaborates with research institutions.

he company generates revenue primarily from B2B partnerships, including collaborative research agreements, licensing arrangements and commercialization partnerships with pharmaceutical companies and healthcare institutions.

Youseen is preparing to explore international market entry, particularly in selected Asian and European regions.

## Funding rounds

- Series E, Aug 24, 2025 — Gortune Investment, Foshan Venture Capital
- Series D, Dec 27, 2018 — Liyuan Venture Capital, Langtaosha Venture Capital, Zhuhai Longmen Capital Management, Zhuhai Hengqin Kangyuan Huiying Investment Management, Zhejiang Gcredit Investment Management, Suzhou Longmen Venture Capital
- Series A, Feb 28, 2010 — Sinowisdom, Bluesource Capital

## Investors

- Sinowisdom (https://capitalatlas.ai/funds/sinowisdom) — Series A
- Bluesource Capital (https://capitalatlas.ai/funds/bluesource-capital) — Series A
- Liyuan Venture Capital (https://capitalatlas.ai/funds/liyuan-venture-capital) — Series D
- Langtaosha Venture Capital (https://capitalatlas.ai/funds/langtaosha-venture-capital) — Series D
- Zhuhai Longmen Capital Management (https://capitalatlas.ai/funds/zhuhai-longmen-capital-management) — Series D
- Zhuhai Hengqin Kangyuan Huiying Investment Management — Series D
- Zhejiang Gcredit Investment Management (https://capitalatlas.ai/funds/zhejiang-gcredit-investment-management) — Series D
- Suzhou Longmen Venture Capital (https://capitalatlas.ai/funds/suzhou-longmen-venture-capital) — Series D
- Gortune Investment (https://capitalatlas.ai/funds/gortune-investment) — Series E
- Foshan Venture Capital — Series E